NCT06863129

Brief Summary

The goal of this clinical trial is to find out if removing and replacing part of the hip bone works better than using metal hardware to stabilize the bone in patients whose cancer has spread to the hip. The main questions are:

  • Be randomly assigned to one of two groups (internal fixation or resection and reconstruction).
  • Have one of the two surgeries based on which group they're in.
  • Go to follow-up appointments with the study doctor at 2 weeks, 6 weeks, 4 months, 6 months, 9 months, and 12 months after surgery.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
334

participants targeted

Target at P75+ for not_applicable

Timeline
50mo left

Started Feb 2025

Longer than P75 for not_applicable

Geographic Reach
4 countries

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Feb 2025Jun 2030

Study Start

First participant enrolled

February 1, 2025

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

February 4, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 7, 2025

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2030

Last Updated

November 10, 2025

Status Verified

March 1, 2025

Enrollment Period

4.3 years

First QC Date

February 4, 2025

Last Update Submit

November 7, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Mortality at 12 months

    Collected through case report forms via electronic medical records and patient/ caregiver self-reported.

    From enrollment to one year follow-up post surgery.

  • Physical function

    Patient-Reported Outcomes Measurement Information System (PROMIS®) Global Physical Function score: To what extent are you able to carry out your everyday physical activities such as walking, climbing stairs, carrying groceries, or moving a chair? Answer options include: Completely (best outcome); Mostly; Moderately; A little; Not at all (worst outcome)

    From enrollment to one year follow-up post surgery.

  • Number of days at home

    Patient self- reported via patient diary.

    From enrollment to one year follow-up post surgery.

Secondary Outcomes (1)

  • Quality of life- PROMIS-PROPr (PROMIS-Preference) health utility score

    From enrollment to one year follow-up post surgery.

Study Arms (2)

Resection and Reconstruction

EXPERIMENTAL

If a participant is randomized to the Resection and Reconstruction treatment arm, a proximal femoral resection or hip arthroplasty will be carried out as per standard surgical practice. The type of endoprosthesis used for reconstruction will be at the treating surgeon's discretion. Acetabular reconstruction (if any), the surgical approach, and the intra-operative use of cement and other adjuvants for disease control will also be at the discretion of the treating surgeon.

Procedure: Resection and reconstruction

Internal Fixation

ACTIVE COMPARATOR

If the participant is randomized to the Internal Fixation treatment arm, the surgery will involve the stabilization of the remaining bone with either an intramedullary nail, plate or screw fixation. All standard surgical principles of stable internal fixation will be followed. The type of fixation, the surgical approach, and the intra-operative use of cement and other adjuvants for disease control will be at the treating surgeon's discretion.

Procedure: Internal Fixation

Interventions

Internal Fixation

Internal Fixation

Resection and reconstruction

Resection and Reconstruction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Life expectancy of at least 6 months
  • Lesions in the proximal femur (femoral neck, intertrochanteric region, subtrochanteric region, and combinations thereof)
  • Low or intermediate risk for perioperative morbidity and/or mortality
  • No more than 75% and no less than 25% bone loss
  • Mutual (patient and physician) decision to perform surgical management of an impending or realized pathologic fracture due to MBD of the proximal has been made.

You may not qualify if:

  • Lesions isolated to the femoral neck
  • Lesion with any femoral head involvement
  • High risk for perioperative morbidity and/or mortality
  • Multidisciplinary decision that resection of the entire lesion would be indicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Parkview Packnett Family Cancer Institute

Fort Wayne, Indiana, 46845, United States

RECRUITING

Good Samaritan Regional Medical Center

Corvallis, Oregon, 97330, United States

RECRUITING

Oregon Health and Science University Hospital

Portland, Oregon, 97239, United States

NOT YET RECRUITING

Cliniques Universitaires Saint-Luc

Brussels, 1200, Belgium

NOT YET RECRUITING

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, 90450050, Brazil

RECRUITING

AOU Città della Salute e della Scienza CTO hospital

Torino, To, 10126, Italy

NOT YET RECRUITING

Related Publications (1)

  • Axelrod D, Gazendam AM, Ghert M. The Surgical Management of Proximal Femoral Metastases: A Narrative Review. Curr Oncol. 2021 Sep 28;28(5):3748-3757. doi: 10.3390/curroncol28050320.

    PMID: 34677238BACKGROUND

MeSH Terms

Conditions

Bone Diseases

Interventions

Fracture Fixation, InternalPlastic Surgery Procedures

Condition Hierarchy (Ancestors)

Musculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Fracture FixationOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Study Officials

  • Michelle Ghert, MD

    McMaster University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 4, 2025

First Posted

March 7, 2025

Study Start

February 1, 2025

Primary Completion (Estimated)

June 1, 2029

Study Completion (Estimated)

June 1, 2030

Last Updated

November 10, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Protocol will be shared with other researchers via the study website.

Shared Documents
STUDY PROTOCOL
Time Frame
Throughout study period.
Access Criteria
Publicly available.
More information

Locations